DOI: 10.26717/BJSTR.2017.01.000198
Corresponding author:
Yusuf Ziya Şener, Faculty of Medicine, Department of Internal Medicine, Hacettepe University, TurkeyReceived: July 10, 2017; Published: July 18, 2017
To view the Full Article Peer-reviewed Article PDF
Bisphosphonates (BPs) are important drugs in treatment and prevention of all types of osteoporosis. BRONJ is a well known complication of BP treatment since 2002 when it was firstly described. Although most of the reported cases are patients with malignancies. Rheumatoid arthritis is a well known risk factor for BRONJ. In this report, we present a patient with BRONJ who was in our follow up due to rheumatoid arthritis.
Introduction| Case Report| Discussion| Conclusion| References|